Clinical trial
Prophylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac Arrest With Initial Shockable Rhythm.
NCT06835491 is registered in ClinicalTrials.gov with Versailles Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prophylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac Arrest With Initial Shockable Rhythm.
- Lead sponsor
- Versailles Hospital
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- November 6, 2025
- Completion date
- March 15, 2027
- Enrollment
- 674 (estimated)
- Sites
- 29
Conditions
As the registry lists them; a condition with its own page is linked.
ventricular arrhythmias and cardiac arrest